Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989;28(Suppl 1):78S–81S. doi: 10.1111/j.1365-2125.1989.tb03580.x

The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog

S E Hadfield, S-J Slee, H M Snow
PMCID: PMC1379883  PMID: 2572262

Abstract

An anaesthetised dog preparation was used to examine the pharmacological profiles of xamoterol, cicloprolol, prenalterol and pindolol. The effects of these agents on heart rate and hind limb perfusion pressure revealed that xamoterol is highly cardioselective and has no significant agonist activity at β2-receptors and no membrane stabilising effect. These pharmacological properties are not complicated by the formation of active metabolites and may explain the clinical benefits in the long-term treatment of heart failure.

Keywords: xamoterol, cicloprolol, prenalterol, pindolol

Full text

PDF
78S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bilski A. J., Halliday S. E., Fitzgerald J. D., Wale J. L. The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430–437. doi: 10.1097/00005344-198305000-00013. [DOI] [PubMed] [Google Scholar]
  2. Binkley P. F., Lewe R. F., Lima J. J., Al-Awwa A., Unverferth D. V., Leier C. V. Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Circulation. 1986 Dec;74(6):1390–1398. doi: 10.1161/01.cir.74.6.1390. [DOI] [PubMed] [Google Scholar]
  3. Currie P. J., Kelly M. J., Middlebrook K., Federman J., Sainsbury E., Ashley J., Pitt A. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. Br Heart J. 1984 May;51(5):530–538. doi: 10.1136/hrt.51.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lambertz H., Meyer J., Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984 Feb;69(2):298–305. doi: 10.1161/01.cir.69.2.298. [DOI] [PubMed] [Google Scholar]
  5. Nuttall A., Snow H. M. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist. Br J Pharmacol. 1982 Oct;77(2):381–388. doi: 10.1111/j.1476-5381.1982.tb09309.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES